Did anyone else hear in the interview that CYGX had developed a special peptide chain that would only penetrate bacterial walls and not mammalian cell walls? This means that their delivery system is getting very cell specific.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.